Dietary calcium, blood pressure and cell membrane cation transport systems in males
- PMID: 8557965
- DOI: 10.1097/00004872-199508000-00008
Dietary calcium, blood pressure and cell membrane cation transport systems in males
Abstract
Objective: A double-blind, placebo-controlled parallel-group study was conducted on the effect of a high level of daily oral calcium supplementation (1 g elemental calcium given twice a day for 16 weeks) in normal male subjects on blood pressure, intracellular cationic concentrations and transmembrane cation transport systems, plasma total and ionized calcium, and calciotropic hormones.
Methods: After a 1-month run-in period with a limited intake of dairy products, the 32 subjects were allocated to a placebo or a calcium group. Placebo or 1 g elemental calcium was administered twice a day, in the morning and evening, for 16 weeks. All subjects were investigated at baseline and after 1, 2, 4, 8 and 16 weeks of placebo or calcium administration.
Results: Compared with the placebo group, standing systolic blood pressure was decreased in the calcium group, whereas the standing diastolic blood pressure tended to decrease. The changes in supine systolic and diastolic blood pressure did not differ between the placebo and calcium groups. Decreased intra-erythrocyte and intraplatelet sodium and calcium concentrations, an increased activity of platelet and erythrocyte sodium-pump activity and a reduced membrane cholesterol content were observed in the calcium-treated subjects. Erythrocyte membrane surface and core microviscosity, however, did not change during calcium supplementation. Oral calcium supplementation in these men was accompanied by a reduction in the plasma concentrations of intact parathormone and 1,25-dihydroxyvitamin D3, and an increase in 24 h urinary calcium excretion, but no change in the plasma total calcium concentration, serum ionized calcium level, or plasma phosphate or 25-hydroxyvitamin D3. The intra-erythrocyte and intraplatelet potassium and magnesium concentrations as well as the activities of the erythrocyte Na,Li-countertransporter and Na,K-cotransporter, and sodium and potassium leakage did not change during calcium administration.
Conclusions: The lowering of standing blood pressure seen in men with a high calcium intake is accompanied by a decrease in cytosolic free platelet calcium and total erythrocyte calcium, by a reduction in intraplatelet and intra-erythrocyte sodium concentration and erythrocyte membrane cholesterol and by an increase in the activity of the erythrocyte and platelet sodium-pump.
Similar articles
-
Modification of intracellular calcium and plasma renin by dietary calcium in men.Am J Hypertens. 1999 Dec;12(12 Pt 1-2):1217-24. doi: 10.1016/s0895-7061(99)00126-0. Am J Hypertens. 1999. PMID: 10619585 Clinical Trial.
-
Cell membrane cation transport systems during aldosterone antagonism.J Cardiovasc Pharmacol. 1996 Apr;27(4):462-8. doi: 10.1097/00005344-199604000-00002. J Cardiovasc Pharmacol. 1996. PMID: 8847860 Clinical Trial.
-
Blood pressure and cationic transport systems during combined calcium channel blocker and calcium administration in males.Methods Find Exp Clin Pharmacol. 1996 May;18(4):287-94. Methods Find Exp Clin Pharmacol. 1996. PMID: 8803961 Clinical Trial.
-
The effect of dietary interventions to reduce blood pressure in normal humans.J Am Coll Nutr. 1989 Dec;8(6):495-503. doi: 10.1080/07315724.1989.10720319. J Am Coll Nutr. 1989. PMID: 2695549 Review.
-
Symposium on diversity of membrane cation transport in vertebrate red blood cells. An overview.Comp Biochem Physiol Comp Physiol. 1992 Aug;102(4):595-6. doi: 10.1016/0300-9629(92)90709-y. Comp Biochem Physiol Comp Physiol. 1992. PMID: 1355020 Review. No abstract available.
Cited by
-
Potassium, magnesium, and calcium: their role in both the cause and treatment of hypertension.J Clin Hypertens (Greenwich). 2008 Jul;10(7 Suppl 2):3-11. doi: 10.1111/j.1751-7176.2008.08575.x. J Clin Hypertens (Greenwich). 2008. PMID: 18607145 Free PMC article. Review.
-
Calcium supplementation for prevention of primary hypertension.Cochrane Database Syst Rev. 2022 Jan 11;1(1):CD010037. doi: 10.1002/14651858.CD010037.pub4. Cochrane Database Syst Rev. 2022. PMID: 35014026 Free PMC article.
-
Vitamins and Minerals for Blood Pressure Reduction in the General, Normotensive Population: A Systematic Review and Meta-Analysis of Six Supplements.Nutrients. 2023 Sep 30;15(19):4223. doi: 10.3390/nu15194223. Nutrients. 2023. PMID: 37836507 Free PMC article.
-
Calcium supplementation for prevention of primary hypertension.Cochrane Database Syst Rev. 2021 Aug 10;8(8):CD010037. doi: 10.1002/14651858.CD010037.pub3. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 Jan 11;1:CD010037. doi: 10.1002/14651858.CD010037.pub4. PMID: 34693985 Free PMC article. Updated.
-
Calcium supplementation for prevention of primary hypertension.Cochrane Database Syst Rev. 2015 Jun 30;2015(6):CD010037. doi: 10.1002/14651858.CD010037.pub2. Cochrane Database Syst Rev. 2015. Update in: Cochrane Database Syst Rev. 2021 Aug 10;8:CD010037. doi: 10.1002/14651858.CD010037.pub3. PMID: 26126003 Free PMC article. Updated.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical